1. Big Data and Bioinformatics

The exponential growth in biological data, driven by advancements in sequencing technologies and high-throughput experiments, has made bioinformatics an indispensable tool. By 2030, we anticipate:

• Petabyte-Scale Data Management: Enhanced storage solutions and cloud computing platforms will allow researchers to handle the vast amounts of data generated from omics studies, including genomics, transcriptomics, and proteomics.

• AI and Machine Learning Integration: Sophisticated algorithms will uncover patterns and relationships in large datasets, enabling predictions about gene function, disease susceptibility, and therapeutic outcomes.

2. Personalized Medicine and Genomics

Bioinformatics will play a pivotal role in tailoring healthcare to individual patients. Key developments include:

• Whole-Genome Sequencing in Clinics: The decreasing cost of sequencing will make it routine in medical diagnostics, enabling personalized treatment plans based on an individual’s genetic makeup.

• Drug Repurposing and Development: Computational tools will identify potential new uses for existing drugs, accelerating the development of targeted therapies.

3. Advancing Computational Tools

The future will see the development of more user-friendly and powerful bioinformatics tools:

• Graph-Based Approaches: Enhanced algorithms for analyzing complex biological networks, such as protein-protein interaction maps.

• Visualization Tools: Intuitive software for visualizing multi-dimensional data, enabling researchers to interpret findings more effectively.

4. Synthetic Biology and Systems Biology

Bioinformatics will continue to drive progress in synthetic and systems biology by:

• Gene Circuit Design: Leveraging computational models to design and simulate synthetic biological systems.

• Understanding Cellular Pathways: Integrating multi-omics data to model cellular processes with unprecedented accuracy.

5. Bioinformatics in Agriculture and Environmental Science

Beyond healthcare, bioinformatics will revolutionize agriculture and environmental conservation:

• Crop Improvement: Genomic studies will help develop high-yield, disease-resistant, and climate-resilient crops.

• Microbial Ecology: Metagenomics will enhance our understanding of microbial communities, aiding in bioremediation and ecosystem management.

6. Democratization of Bioinformatics

Open-source software and accessible education will broaden participation in bioinformatics research:

• Community-Driven Projects: Collaborative platforms like GitHub will continue to foster innovation in tool development.

• Education and Training: Online courses and workshops will bridge skill gaps, enabling researchers from diverse backgrounds to contribute.

Challenges and Ethical Considerations

While the future is bright, challenges remain. Data privacy and ethical concerns surrounding genetic information require careful navigation. Furthermore, addressing the digital divide is critical to ensuring equitable access to bioinformatics resources globally.

Conclusion

The future of bioinformatics is boundless, with opportunities to revolutionize our understanding of life and improve human health. As technologies evolve and collaborations flourish, bioinformatics will undoubtedly remain at the forefront of scientific discovery, unlocking the secrets of life one dataset at a time.

Louisiana Biomedical Research Network (LBRN) announces registration for it's Summer 2019 Bioinformatics Training Program. The program will be focused on processing, analysis and interpretation of next generation sequecning data for biologists. Learn more:

https://edu.t-bio.info/louisiana-biomedical-research-network-summer-2019-lbrn-bioinformatics-training-program/

Address of the bookmark: https://bioinformatik.de/en/bioinformatics-in-germany/research/research-groups.html

https://bioalgorithms.ucsd.edu/research4.html

ICGEB NEW DELHI, INDIA

Biotechnology research positions

Projects include:

a) protein structure determination
b) malaria parasite biology
c) genomics and metagenomics
d) molecular and cellular biology
e) bioinformatics and computational biology

Minimum eligibility for students who have already obtained a MSc:

1) INSPIRE award for PhD
2) SPM award for PhD
3) CSIR/DBT/DST JRF for PhD

Applicants should submit their curriculum vitae by email to: sb.icgeb@gmail.com by 30 August 2016

SciGenom Research Foundation (SGRF) and Institute of Genomics and Integrative Biology (IGIB) are pleased to host the Next-Generation Sequencing and Bioinformatics for Genomics & Healthcare conference.

In the ten years since the first human reference genome was completed for US$3 billion the sequencing technologies have radically changed leading to great reduction in sequencing cost. Today a human genome can be sequenced for under US$ 5000 in less than two weeks. It is expected that by the end of 2015 the cost of sequencing a human genome will drop to below thousand dollars. The next generation sequencing technologies over the past five years have enabled a large number of genomic studies that impact human health and disease. Also, this has made possible the growth of microbial, animal and plant genomics studies. While the data production has increased at a rapid pace challenges remain in analyzing and understanding the data. The conference will cover the next generation sequencing (NGS) technologies, bioinformatics for NGS and applications of NGS in many areas including personalized medicine.

For more info : http://www.scigenomconferences.com/2013/default.php

Biocon, India's largest publicly-held biotechnology firm, launched its second novel 'lab-to-market' molecule, Alzumab, to treat chronic plaque psoriasis at a cost 50 per cent lower than the existing one.

Biocon is bringing Alzumab (a biologic) in the form of a vial after working on it for nearly a decade. The work had initially started in a joint effort with the Center of Molecular Immunology, Havana, but Biocon took control of the programme soon after and also bought out its partner a few years ago. Biocon tell to the media that genotypic played a critical role in functional studies and clinical trial Genomics.

The Biocon drug, at around ₹ 7,500 a vial, will cost half as much as the currently available drugs - from Pfizer and J&J - to treat psoriasis, a skin disease that causes rough red areas where the skin comes off in small pieces. A patient is usually prescribed to consume more than 40 vials in a 24-week course.

More @ http://bioinfo-presiuniv.edu.in/index.php

More @ http://www.ncbs.res.in/sowdhamini/groups_sowdhamini.htm

The objective of this conference is two-fold:

Understanding different algorithms of MD and their relevant applications.
Hands-on practical exercises using NAMD.

More at http://ccbb.jnu.ac.in/advmdbio/